1:5 Stock Split!!! This High Quality Small Cap API Manufacturer Soars to New Heights with Powering Growth! (Gujarat Themis Biosyn Ltd share)

Gujarat Themis Biosyn Ltd, incorporated in 1981, specializes in manufacturing and selling finished Active Pharmaceutical Ingredients (API) products. Utilizing advanced techniques, the company excels in the fermentation process, ensuring the production of high-quality API products. With a strong commitment to innovation and customer satisfaction, Gujarat Themis Biosyn Ltd remains at the forefront of the pharmaceutical industry, contributing to the well-being of countless individuals worldwide.

Click on the picture below to Open Demat account with Zerodha

Company achieved 29.7% YoY growth in Revenues in FY22-23
Company is debt-free on net debt basis
Product Portfolio : Rifamycins – Treatment of Tuberculosis and digestive tract infections
Company is the First to start commercial production of Rifampicin using Fermentation process
Strong Collaborations: TML has been open to Technical and commercial collaborations so that GTBL can adopt best technologies and best processes
Fungible Capacities of up to 16,000 KG/Months

The company has recently announced 5-for-1 stock split i.e., for every old share you held, you would receive fuve new shares with the adjusted lower face value. Here,

Old face value: Rs. 5
New face value: Rs. 1

In a stock split, the company increases the number of shares outstanding while simultaneously decreasing the stock’s price per share. This is usually done to make the stock more affordable to a wider range of investors and to improve liquidity.

The stock split will be effective on October 10, 2023.

The company’s market capitalization is about ₹1,487 Crores.
The current stock price stands at ₹1023, with a high/low range of ₹1044 to ₹572.
The stock’s P/E ratio is at 25.7, while the book value is ₹103, and the dividend yield is 0.53%.
The company exhibits a robust financial performance with an ROCE of 61.1% and an ROE of 45.9%.
With a face value of ₹5.00 and a debt-to-equity ratio of Zero, it maintains a healthy financial structure. Additionally, there is no pledged percentage of shares, highlighting a low level of risk.

The technical parameters for Gujarat Themis Biosyn Ltd share are as follows:

RSI: RSI is strongly overbought at 84.4.
MFI: MFI is strongly overbought at 83.9.
Beta 1Year: The stock has very low volatility.
50-Day SMA: The price is above the 50-Day Simple Moving Average (SMA) at Rs 826.8.
200-Day SMA: The price is above the 200-Day SMA at Rs 759.9.

Here are the resistance and support levels for Gujarat Themis Biosyn Ltd share:

Resistance:

R1: 1053.20
R2: 1083.05
R3: 1122.10

Support:

S1: 984.30
S2: 945.25
S3: 915.40

Also read: Have a look at the following story:

Stocks bought by Ace Investor Mukul Agarwal !!! Do you own any

Disclaimer:

This is not a stock recommendations. All efforts have been made to correctly represent facts and figures in the post. The website or its management is not responsible for any kind of losses arising out of Investing in equities. Investors must therefore exercise due caution while investing or trading in stocks. NSE Options.in or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing